RAPAPORT. The International Gemological Institute (IGI) has updated its grading report for synthetic diamonds to include information about post-growth treatments.
The reports will now outline the growth process for untreated chemical vapor deposition (CVD) or High Pressure-High Temperature (HPHT) stones, the lab said Wednesday. They will also specifically indicate those diamonds are “as grown with no indication of post-growth treatment.”
Previously, IGI, which has issued lab-grown reports since 2005, only indicated that synthetic diamonds “may include post-growth treatments to alter color.” Any CVD stones that are not definitively found to be untreated will still carry this description, IGI noted.
“The popularity of lab-grown diamonds has heightened since IGI debuted the industry’s first [reports] 16 years ago,” said IGI CEO Roland Lorie. “As the technology advances and demand evolves, the institute will continue to do right by the consumer.”
Religious Beliefs May Associate With Cardiovascular Disease by Karishma Abhishek on January 17, 2021 at 6:24 PM
Religious beliefs modify a unique protein that is on the risk of developing cardiovascular disease (CVD) among U.S. South Asians as per a Study on Stress, Spirituality and Health (SSSH), a cutting-edge proteomics analysis at Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC) and the University of California San Francisco (UCSF) published in the journal Scientific Reports.
This is the first study to analyze proteomics signatures in relationship to religion and spirituality in any population. Religiosity and Cardiovascular Disease
‘Religious beliefs modify a unique protein that is on the risk of developing cardiovascular disease (CVD) among U.S. South Asians. This helps in understanding the further molecular mechanisms that may contribute to the development of the CVD.’
Nissan Kicks 1.3 Turbo CVT review, test drive
Nissan’s tough SUV is now more user friendly. Nissan has finally introduced an auto gearbox for the
Kicks, and the configuration offered is a CVT (continuously variable transmission) paired to a 1.3-litre turbo-petrol engine. At
prices ranging between Rs 13.45 and 14.15 lakh (ex-showroom, India), it is available only in mid-spec variants, commanding a premium of Rs 1.50-1.60 lakh over its manual counterparts. The 1.3-litre turbo-petrol comes with an impressive resume – it has been co-developed by the
Mitsubishi Alliance and Daimler. It even shares some of its state-of-the-art engineering with the
Nissan GT-R supercar; and it produces a class-best 156hp and 254Nm of torque. And it shines in the real world too with its smoothness, linear power delivery and responsiveness. Its wide torque spread from as low as 1,600rpm and strong mid-range performance makes light work of darting into traffic gaps, cruising at highway speeds